SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities

被引：246

作者：

Walensky, Rochelle P. ^{[1
]}

Walke, Henry T. ^{[1
]}

Fauci, Anthony S. ^{[2
]}

机构：

[1] Ctr Dis Control & Prevent, 1600 Clifton Rd, Atlanta, GA 30333 USA

[2] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2021年 / 325卷 / 11期

关键词：

D O I：

10.1001/jama.2021.2294

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This Viewpoint from directors at the CDC and NIH describes measures that federal agencies are taking to rapidly characterize emerging coronavirus variants and monitor their implications for national pandemic response and control, including assessment of ongoing effectiveness of current diagnostics, therapeutics, and vaccines.

引用

页码：1037 / 1038

页数：2

共 9 条

[1]

Faria NR., 2021, GENOMIC CHARACTERISA, V372, P815

[2] First Identified Cases of SARS- CoV-2 Variant B.1.1.7 in Minnesota - December 2020-January 2021 [J].

Firestone, Melanie J. ;

Lorentz, Alexandra J. ;

Wang, Xiong ;

Como-Sabetti, Kathryn ;

Vetter, Sara ;

Smith, Kirk ;

Holzbauer, Stacy ;

Meyer, Stephanie ;

Ehresmann, Kristin ;

Danila, Richard ;

Lynfield, Ruth .

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (08) :278-279

[3]

Galloway SE, 2021, MMWR-MORBID MORTAL W, V70, P95, DOI [10.15585/mmwr.mm7003e2externalicon, 10.15585/mmwr.mm7003e2]

[4]

Horby P., SAGE M REP JAN 21

[5]

Mwenda M, 2021, MMWR-MORBID MORTAL W, V70, P280, DOI [10.15585/mmwr.mm7008e2, 10.15585/mmwr.mm7008e2externalicon]

[6]

Wang PF, 2021, bioRxiv, DOI [10.1101/2021.01.25.428137, 10.1101/2021.01.25.428137, DOI 10.1101/2021.01.25.428137]

[7]

Washington Nicole L, 2021, medRxiv, DOI 10.1101/2021.02.06.21251159

[8]

WHO, 2021, Weekly epidemiological update on COVID-19-22 June 2021

[9]

Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]

← 1 →